Biotechnology Stocks I Performance Guide: Exelixis, Inc. (EXEL)
EXEL has no dividends.
Table and Chart of EXEL Performance
See what a $1,000 investment in EXEL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| EXEL Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $3.31 |
| End Date | May-08-2024 |
| End Price | $21.59 |
| # Prices | 121 |
| Min Date | Dec-31-2014 |
| Min Price | $1.44 |
| Max Date | Dec-29-2017 |
| Max Price | $30.40 |
| Total Return | 552.27% |
| Annualized Return | 20.44% |
| Current Value of $1,000 Purchase | $6,523 |
| Number Returns | 7,260 |
| Average Return | 190.76% |
| Number Profitable Returns | 4,901 |
| Percent Profitable Returns | 67.51% |
| Number Unprofitable Returns | 2,359 |
| Percent Unprofitable Returns | 32.49% |
| Profitable to Unprofitable Returns Ratio | 2.08 |
| EXEL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $6,289,016,000 |
| Beta | 0.571 | Price to Sales | 3.78 |
| Earnings per Share | $0.6500 |
| PE Ratio | 33.22 |
| PE to Growth Ratio | 1.686 |
| Price to Book | 3.055 |
| PRICE DATA | |
| 52 Week High | $24.34 |
| 52 Week Low | $18.64 |
| Analyst Target Price | $26.74 |
| 50-Day Moving Average | $22.95 |
| 200-Day Moving Average | $21.97 |
| FINANCIAL DATA | |
| Revenue per Share | $5.91 |
| Revenue | $1,846,646,000 |
| Profit Margin | 11.1% |
| Return on Equity | 8.76% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
EXEL Compare Returns with S&P 500
EXEL Trendline Chart
EXEL Moving Average Chart
EXEL Stock Return Map - See Patterns of Gains and Losses
EXEL Stock Returns/Purchase Dates